Search research articles
Contact Us
Filters
Showing results (481-490 of 561) with videos related to
Page
of 57
Sort By:
Circulation
|
October 26, 2018
Heart Centers for Women: Historical Perspective on Formation and Future Strategies to Reduce Cardiovascular Disease
Gina P Lundberg, Laxmi S Mehta, Rupa M Sanghani, et al.
Mucosal Immunology
|
May 23, 2014
Foxp3+ regulatory T cells promote lung epithelial proliferation
J R Mock, B T Garibaldi, N R Aggarwal, et al.
JACC. Advances
|
June 28, 2024
Recommendations for the Management of High-Risk Cardiac Delivery: ACC Cardiovascular Disease in Women Committee Panel
Emily S Lau, Niti R Aggarwal, Joan E Briller, et al.
Journal of the American College of Cardiology
|
December 12, 2024
2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee
, Mark H Drazner, Biykem Bozkurt, et al.
Cancer Research Communications
|
November 13, 2025
BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Andre L De Souza, Matthew J Hadfield, Shaolei Lu, et al.
Open Heart
|
July 5, 2017
Higher number of live births is associated with left ventricular diastolic dysfunction and adverse cardiac remodelling among US Hispanic/Latina women: results from the Echocardiographic Study of Latinos
Shivani R Aggarwal, David M Herrington, Catherine J Vladutiu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2018
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
A R Hansen, C Massard, P A Ott, et al.
BMC Cancer
|
March 6, 2019
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer
Janice M Mehnert, Andrea Varga, Marcia S Brose, et al.
JAMA Health Forum
|
September 13, 2024
A Machine Learning Method for Allocating Scarce COVID-19 Monoclonal Antibodies
Mengli Xiao, Kyle C Molina, Neil R Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Rahul R Aggarwal, Michael T Schweizer, David M Nanus, et al.
Page
of 57
Search research articles
Search
Showing results (481-490 of 561) with videos related to
Sort By:
Page
of 57
Circulation
|
October 26, 2018
Heart Centers for Women: Historical Perspective on Formation and Future Strategies to Reduce Cardiovascular Disease
Gina P Lundberg, Laxmi S Mehta, Rupa M Sanghani, et al.
Mucosal Immunology
|
May 23, 2014
Foxp3+ regulatory T cells promote lung epithelial proliferation
J R Mock, B T Garibaldi, N R Aggarwal, et al.
JACC. Advances
|
June 28, 2024
Recommendations for the Management of High-Risk Cardiac Delivery: ACC Cardiovascular Disease in Women Committee Panel
Emily S Lau, Niti R Aggarwal, Joan E Briller, et al.
Journal of the American College of Cardiology
|
December 12, 2024
2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee
, Mark H Drazner, Biykem Bozkurt, et al.
Cancer Research Communications
|
November 13, 2025
BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Andre L De Souza, Matthew J Hadfield, Shaolei Lu, et al.
Open Heart
|
July 5, 2017
Higher number of live births is associated with left ventricular diastolic dysfunction and adverse cardiac remodelling among US Hispanic/Latina women: results from the Echocardiographic Study of Latinos
Shivani R Aggarwal, David M Herrington, Catherine J Vladutiu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2018
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
A R Hansen, C Massard, P A Ott, et al.
BMC Cancer
|
March 6, 2019
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer
Janice M Mehnert, Andrea Varga, Marcia S Brose, et al.
JAMA Health Forum
|
September 13, 2024
A Machine Learning Method for Allocating Scarce COVID-19 Monoclonal Antibodies
Mengli Xiao, Kyle C Molina, Neil R Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Rahul R Aggarwal, Michael T Schweizer, David M Nanus, et al.
Page
of 57